Your browser doesn't support javascript.
loading
Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN.
Schnöder, Tina M; Eberhardt, Judith; Koehler, Michael; Bierhoff, Holger B; Weinert, Sönke; Pandey, Akhilesh Datt; Nimmagadda, Subbaiah Chary; Wolleschak, Denise; Jöhrens, Korinna; Fischer, Thomas; Heidel, Florian H.
Affiliation
  • Schnöder TM; Innere Medizin II, Hämatologie und Onkologie, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Germany.
  • Eberhardt J; Leibniz Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.
  • Koehler M; Department of Hematology and Oncology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
  • Bierhoff HB; Department of Hematology and Oncology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
  • Weinert S; Leibniz Institute on Aging, Fritz-Lipmann-Institute, Jena, Germany.
  • Pandey AD; Department of Genetics, Friedrich-Schiller-University, Jena, Germany.
  • Nimmagadda SC; Department of Cardiology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
  • Wolleschak D; Department of Hematology and Oncology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
  • Jöhrens K; Department of Hematology and Oncology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
  • Fischer T; Department of Hematology and Oncology, Otto-von-Guericke University Medical Center, Magdeburg, Germany.
  • Heidel FH; Institut für Pathologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
J Cancer Res Clin Oncol ; 143(5): 807-820, 2017 May.
Article in En | MEDLINE | ID: mdl-28233092

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Janus Kinase 2 / Chemokine CXCL10 / Myeloproliferative Disorders Type of study: Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Animals / Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2017 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Janus Kinase 2 / Chemokine CXCL10 / Myeloproliferative Disorders Type of study: Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Animals / Humans Language: En Journal: J Cancer Res Clin Oncol Year: 2017 Document type: Article Affiliation country: Germany